Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2018;24(2):144-150. Published online January 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0041

View: 8907 Download: 170 Web of Science: 12 Crossref: 11

Review

Strategic application of radiotherapy for hepatocellular carcinoma

Seo Hee Choi, Jinsil Seong

Clin Mol Hepatol. 2018;24(2):114-134. Published online February 14, 2018

DOI: https://doi.org/10.3350/cmh.2017.0073

View: 14057 Download: 384 Web of Science: 36 Crossref: 41

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 10938 Download: 359 Web of Science: 38 Crossref: 34

3

Concurrent Chemo - Radiation Therapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis

Jin Suk Kim, M.D., Kwang-Hyub Han, M.D., Do Yun Lee, M.D.* , Jin-Sil Seong, M.D.† , Young Hoon Youn, M.D., Jae Youn Cheong, M.D., Sang Hoon Ahn, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.

Clin Mol Hepatol. 2002;8(1):71-79. Published online January 1, 1970

View: 2874 Download: 19

1 |

Viewed By 5176	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5034	MAFLD: How is it different from NAFLD?
Viewed By 4978	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3673	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3628	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search